Bevacizumab boosts visual acuity in diabetes patients

04/9/2012 | MedPage Today (free registration)

Patients with diabetic macular edema who received intravitreal bevacizumab shots retained better visual acuity than those who underwent laser photocoagulation, according to a study in the Archives of Ophthalmology. The patients were evaluated one year and two years after the treatments.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC